The Geroscience IndexWho's who in the science of aging
← All labs

Dog Aging Project

Academic

Founded
2014
Location
Seattle, United States; College Station, United States; Boston, United States; Ithaca, United States
Type
Academic

About

The Dog Aging Project is a multi-institution, open-science research programme studying ageing in companion dogs across the United States. It was founded in 2014 by Daniel Promislow, Matt Kaeberlein and Kate Creevy, grew out of an NIA-funded Canine Longevity Consortium, and was funded from 2018 by NIA grant U19AG057377 at the University of Washington. Owners of any dog can enrol; more than 50,000 dogs contribute annual health surveys, veterinary records and environmental data. Smaller cohorts include Foundation (genomics), Precision (biochemistry, with samples in a biobank at Cornell) and TRIAD, a double-blind, placebo-controlled trial of rapamycin in dogs aged at least 7, funded since 2024 by NIH grant R01AG090843 at Texas A&M. De-identified data are released every year to researchers through the Broad Institute's Terra platform. Collaborators come from dozens of veterinary and academic institutions.

Rating breakdown

Aggregate 61/100 · rank #11 in the academic & non-profit table full ratings →

Expand a signal to see what contributes to it.

Publications62
Discovery69
Fundraising94

Grants of the organisation's listed people, name-matched via NIH RePORTER ↗.

  • Matt Kaeberlein: Project 4: Determining the ability of rapamycin to improve lifespan and healthspan in companion dogs · USD 1M · National Institute on Aging 5U19AG057377-05
  • Daniel Promislow: Metabolomics clocks as a tool to explore mechanisms of aging · USD 634K · National Institute on Aging 5R01AG082696-03
  • Daniel Promislow: Metabolomics clocks as a tool to explore mechanisms of aging · USD 627K · National Institute on Aging 5R01AG082696-02
  • Matt Kaeberlein: Core A: Program Enrichment/Administrative · USD 268K · National Institute on Aging 5P30AG013280-28
Education26

Key outputs

Registered clinical trials

2 trials list this organisation as lead sponsor ClinicalTrials.gov ↗

Investment & funding

DateTypeAmountDetailCounterparties
2018-09grantUSD 5MNIH RePORTER publicly disclosed the FY2018 first-year award for U19AG057377, The Dog Aging Project: Genetic and Environmental Determinants of Healthy Aging (University of Washington; PI Promislow)National Institute on Aging (NIH)
2024-12grantUSD 2MNIH RePORTER publicly disclosed the FY2025 first-year award for R01AG090843, Test of Rapamycin in Aging Dogs (TRIAD) (Texas A&M AgriLife Research; PIs Anderson, Creevy, Reed)National Institute on Aging (NIH)

Key people

Daniel PromislowFounder; Dog Aging Project Co-Director and U19 Principal InvestigatorMatt KaeberleinFounder; formerly Co-Director, now listed as Expert ConsultantKate E. CreevyFounder; Chief Veterinary Officer; TRIAD co-PI (Texas A&M)C. Dirk KeeneCo-PI on NIH U19AG057377 (University of Washington); research teamNoah Snyder-MacklerConsortium key personnel; genomics lead (Arizona State University)Audrey RupleConsortium key personnel; epidemiology (Virginia Tech)

Research fields

Links

Sources